DFX Intelligence

Data Factory

Accro Bioscience

series c

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:5901b137-50e1-494f-bb69-e07a0e64b207

Data as of Sep 13, 2026 (this record's last observation) from Sworn filings; Announcements; Limited partners. Page built Sep 20, 2026, 7:26 AM UTC and rebuilt at most every 15 minutes.

Relationships: 10
Dated events: 1
On other graphs: 1
Observed: Sep 13, 2026 to Sep 13, 2026
1 observations

Across DFX

same identity by shared identifier, citation, or a bridge measured by hand

Private Equityidentity

Accro Bioscience

Portfolio company · cited

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Rounds: 1
Latest round: Series C 2026-05-18
Latest round amount: $50.0M
Total disclosed raised: $50.0Mderivedsum of disclosed round sizes only
Investors: 6
People: 0

Rounds

Announced	Round	Stage	Amount	Basis	Investors
May 18, 2026	Series C	Series c	$50.0M	disclosed	n/a

Investors

Investor	Class	Fund	Partner	Role	Attribution
Cenova Capital	Candidate VC	n/a	n/a	participant	Unknown
Orbimed Advisors LLC	PE with venture activity	n/a	n/a	lead	Unknown
Tcgx	Candidate VC	n/a	n/a	participant	Unknown
Lav	Candidate VC	n/a	n/a	participant	Unknown
TCG Crossover	Candidate VC	n/a	n/a	participant	Unknown
Oriza Holdings	Candidate VC	n/a	n/a	participant	Unknown

Relationships

Invested in (10)

← Orbimed Advisors LLCFirmround
May 18, 2026 to presentfactNews and newswire
← TCGXFirmround
May 18, 2026 to presentfactNews and newswire
← LAVFirmround
May 18, 2026 to presentfactNews and newswire
← TCG CrossoverFirmround
May 18, 2026 to presentfactNews and newswire
← May 18Firmround
May 18, 2026 to presentfactNews and newswire
← OrbiMedFirmround
May 18, 2026 to presentfactNews and newswire
← Oriza HoldingsFirmround
May 18, 2026 to presentfactNews and newswire
← Cenova CapitalFirmround
May 18, 2026 to presentfactNews and newswire
← SUZHOUFirmround
May 18, 2026 to presentfactNews and newswire
← ChinaFirmround
May 18, 2026 to presentfactNews and newswire

Dated events

Occurred
May 18, 2026
Round announced
Accro Bioscience announced Series C of $50,000,000, led by OrbiMed
News and newswireobserved 6 days ago
$50.0M

Provenance

Graph: Venture Capital
Canonical id: dfx:vc:5901b137-50e1-494f-bb69-e07a0e64b207
First observed: Sep 13, 2026
Last observed: Sep 13, 2026 6 days ago
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.

Accro Bioscience

series c

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:5901b137-50e1-494f-bb69-e07a0e64b207

Data as of Sep 13, 2026 (this record's last observation) from Sworn filings; Announcements; Limited partners. Page built Sep 20, 2026, 7:26 AM UTC and rebuilt at most every 15 minutes.

Announced

Round

Stage

Amount

Basis

Investors

May 18, 2026

Series C

Series c

$50.0M

disclosed

n/a

Investor

Class

Fund

Partner

Role

Attribution

Cenova Capital

Candidate VC

n/a

participant

Unknown

Orbimed Advisors LLC

PE with venture activity

n/a

lead

Unknown

Tcgx

Candidate VC

n/a

participant

Unknown

Lav

Candidate VC

n/a

participant

Unknown

TCG Crossover

Candidate VC

n/a

participant

Unknown

Oriza Holdings

Candidate VC

n/a

participant

Unknown